• Lidocaine-Tchaikapharma is the company’s newest product with a marketing authorization issued by BDA

    February 2, 2017

    Lidocaine-Tchaikapharma 10 mg and 20 mg solution for injection is Tchaikapharma’s newest product which has obtained a Marketing Authorization issued by the Bulgarian Drug Agency.

    Therapeutic indications:

    • For local anesthesia in surgery, dentistry, urology, cardiology, ophthalmology, otorhinolaryngology and other invasive instrumental investigations.
    • For the treatment of ventricular arrhythmias, including after myocardial infarction and cardiac surgery interventions.


    ATC code: C01BB 01, N01BB 02